The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells

Overview

Journal ACS Synth Biol

Publisher American Chemical Society

Specialties Biotechnology
Molecular Biology

Date 2016 Oct 27

PMID 27783893

Citations 85

Authors

Rene M Daer

Josh P Cutts

David A Brafman

Karmella A Haynes

Affiliations

Soon will be listed here.

Abstract

In order to efficiently edit eukaryotic genomes, it is critical to test the impact of chromatin dynamics on CRISPR/Cas9 function and develop strategies to adapt the system to eukaryotic contexts. So far, research has extensively characterized the relationship between the CRISPR endonuclease Cas9 and the composition of the RNA-DNA duplex that mediates the system's precision. Evidence suggests that chromatin modifications and DNA packaging can block eukaryotic genome editing by custom-built DNA endonucleases like Cas9; however, the underlying mechanism of Cas9 inhibition is unclear. Here, we demonstrate that closed, gene-silencing-associated chromatin is a mechanism for the interference of Cas9-mediated DNA editing. Our assays use a transgenic cell line with a drug-inducible switch to control chromatin states (open and closed) at a single genomic locus. We show that closed chromatin inhibits binding and editing at specific target sites and that artificial reversal of the silenced state restores editing efficiency. These results provide new insights to improve Cas9-mediated editing in human and other mammalian cells.

Citing Articles

From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.

Scherrer C, Loret C, Vedrenne N, Buckley C, Lia A, Kermene V J Tissue Eng. 2025; 16:20417314241310508.

PMID: 40078221 PMC: 11898049. DOI: 10.1177/20417314241310508.

Ten Years of the Synthetic Biology Summer Course at Cold Spring Harbor Laboratory.

Haynes K, Andrews L, Beisel C, Chappell J, Cuba Samaniego C, Dueber J ACS Synth Biol. 2024; 13(9):2635-2642.

PMID: 39300908 PMC: 11421210. DOI: 10.1021/acssynbio.4c00276.

Current landscape in antiviral drug development against herpes simplex virus infections.

Frejborg F, Kalke K, Hukkanen V Smart Med. 2024; 1(1):e20220004.

PMID: 39188739 PMC: 11235903. DOI: 10.1002/SMMD.20220004.

CRISPR Base Editing to Create Potential Charcot-Marie-Tooth Disease Models with High Editing Efficiency: Human Induced Pluripotent Stem Cell Harboring Variants.

Loret C, Pauset A, Faye P, Prouzet-Mauleon V, Pyromali I, Nizou A Biomedicines. 2024; 12(7).

PMID: 39062123 PMC: 11274897. DOI: 10.3390/biomedicines12071550.

Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.

Begum Yagci Z, Kelkar G, Johnson T, Sen D, Keung A Methods Mol Biol. 2024; 2842:23-55.

PMID: 39012589 DOI: 10.1007/978-1-0716-4051-7_2.

References

Bell O, Tiwari V, Thoma N, Schubeler D . Determinants and dynamics of genome accessibility. Nat Rev Genet. 2011; 12(8):554-64. DOI: 10.1038/nrg3017. View

Perez-Pinera P, Kocak D, Vockley C, Adler A, Kabadi A, Polstein L . RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 2013; 10(10):973-6. PMC: 3911785. DOI: 10.1038/nmeth.2600. View

Ran F, Hsu P, Lin C, Gootenberg J, Konermann S, Trevino A . Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013; 154(6):1380-9. PMC: 3856256. DOI: 10.1016/j.cell.2013.08.021. View

Wu X, Scott D, Kriz A, Chiu A, Hsu P, Dadon D . Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol. 2014; 32(7):670-6. PMC: 4145672. DOI: 10.1038/nbt.2889. View

Sparmann A, van Lohuizen M . Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006; 6(11):846-56. DOI: 10.1038/nrc1991. View

Katoh K, Standley D . MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013; 30(4):772-80. PMC: 3603318. DOI: 10.1093/molbev/mst010. View

Xie R, Everett L, Lim H, Patel N, Schug J, Kroon E . Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell. 2013; 12(2):224-37. PMC: 3619036. DOI: 10.1016/j.stem.2012.11.023. View

Squazzo S, OGeen H, Komashko V, Krig S, Jin V, Jang S . Suz12 binds to silenced regions of the genome in a cell-type-specific manner. Genome Res. 2006; 16(7):890-900. PMC: 1484456. DOI: 10.1101/gr.5306606. View

Valton J, Dupuy A, Daboussi F, Thomas S, Marechal A, Macmaster R . Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. J Biol Chem. 2012; 287(46):38427-32. PMC: 3493886. DOI: 10.1074/jbc.C112.408864. View

10.

Cavalli G, Paro R . Epigenetic inheritance of active chromatin after removal of the main transactivator. Science. 1999; 286(5441):955-8. DOI: 10.1126/science.286.5441.955. View

11.

Bernstein B, Mikkelsen T, Xie X, Kamal M, Huebert D, Cuff J . A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006; 125(2):315-26. DOI: 10.1016/j.cell.2006.02.041. View

12.

Simon J, Kingston R . Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell. 2013; 49(5):808-24. PMC: 3628831. DOI: 10.1016/j.molcel.2013.02.013. View

13.

Horlbeck M, Witkowsky L, Guglielmi B, Replogle J, Gilbert L, Villalta J . Nucleosomes impede Cas9 access to DNA in vivo and in vitro. Elife. 2016; 5. PMC: 4861601. DOI: 10.7554/eLife.12677. View

14.

Hansen K, Bracken A, Pasini D, Dietrich N, Gehani S, Monrad A . A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol. 2008; 10(11):1291-300. DOI: 10.1038/ncb1787. View

15.

Kanduri M, Sander B, Ntoufa S, Papakonstantinou N, Sutton L, Stamatopoulos K . A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. Epigenetics. 2013; 8(12):1280-8. PMC: 3933489. DOI: 10.4161/epi.26546. View

16.

Sanchez-Rivera F, Jacks T . Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer. 2015; 15(7):387-95. PMC: 4530801. DOI: 10.1038/nrc3950. View

17.

Isaac R, Jiang F, Doudna J, Lim W, Narlikar G, Almeida R . Nucleosome breathing and remodeling constrain CRISPR-Cas9 function. Elife. 2016; 5. PMC: 4880442. DOI: 10.7554/eLife.13450. View

18.

Hsu P, Lander E, Zhang F . Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014; 157(6):1262-1278. PMC: 4343198. DOI: 10.1016/j.cell.2014.05.010. View

19.

Chen X, Rinsma M, Janssen J, Liu J, Maggio I, Goncalves M . Probing the impact of chromatin conformation on genome editing tools. Nucleic Acids Res. 2016; 44(13):6482-92. PMC: 5291272. DOI: 10.1093/nar/gkw524. View

20.

Bultmann S, Morbitzer R, Schmidt C, Thanisch K, Spada F, Elsaesser J . Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res. 2012; 40(12):5368-77. PMC: 3384321. DOI: 10.1093/nar/gks199. View